6:20 PM
 | 
Aug 11, 2008
 |  BC Extra  |  Company News

Enzon seeking alternatives for specialty pharma unit

Enzon (NASDAQ:ENZN) said it is exploring strategic alternatives for its specialty pharmaceutical business even as the company continues to pursue a plan to spin out its biotech business. The company said the...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >